12.08.2020PIC Therapeutics Appoints Dr. Katherine Bowdish as Chief Executive Officer

Press Release
12.08.2020F2G Closes US$60.8 Million Financing to fund late stage development of novel mechanism antifungal agent

Press Release
11.08.2020Advent Life Sciences announces sale of its portfolio Company KaNDy Therapeutics to Bayer AG for USD 425M upfront plus USD 450M in potential development milestones followed by further potential commercial milestones.

Press Release
06.08.2020Acutus Medical Announces Pricing of Initial Public Offering

Press Release
17.07.2020Zikani Therapeutics Appoints Chief Scientific and Medical Officer

Press Release
24.06.2020Artax Biopharma Announces the Formation of Scientific Advisory Board to Advance Autoimmune Disease Therapy AX-158

Press Release
04.06.2020 Artax Biopharma Announces Series B Financing Extension to Advance First-in-Class Autoimmune Disease Therapy

Press Release
04.06.2020 Axonics® Announces U.S. Food & Drug Administration Approval of Wireless Patient Remote Control with SmartMRI Technology

Press Release
21.05.2020Amphista Therapeutics appoints leading protein degradation pioneer, Ian Churcher as CSO

Press Release
13.05.2020Artax Biopharma Appoints Joseph Lobacki as Chief Executive Officer, Announces Expanded Management Team

Press Release